Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 42708-144

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 42708-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 144 30)

Label (42708 144 30)
Atorvastatin Calcium tablet label showing 40 mg strength in a package of 30 tablets. The label includes instructions for dosage to be filled in, storage instructions for controlled room temperature, and distributor information for QPharma, Inc., Cedar Knolls, NJ. It is marked as a sample not for sale and Rx only.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
A line graph comparing the cumulative incidence percentage over time in years between Atorvastatin and placebo groups. The graph shows lower cumulative incidence for Atorvastatin compared to placebo from 0 to 3.5 years. Hazard ratio (HR) and p-value are displayed below the x-axis, indicating statistical data of the comparison.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
A line graph comparing the cumulative hazard (%) over time (years) up to 5 years for Atorvastatin versus placebo. The x-axis represents time to first primary endpoint through 4 years of follow-up, and the y-axis shows cumulative hazard percentage. Two lines are shown: a solid line for Atorvastatin and a dashed line for placebo, with the placebo group consistently higher. Statistical data includes hazard ratio (HR) 0.63 (0.48-0.83) and p=0.001.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
A line graph depicting the percentage of subjects experiencing a major cardiovascular event over 5 years, comparing Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The 10 mg dose is shown with a dashed line, and the 80 mg dose with a solid line. The graph includes a hazard ratio (HR) of 0.78 with confidence interval 0.69-0.89 and a p-value of 0.0002.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)
Chemical structure diagram of Atorvastatin Calcium, depicting atoms and bonds, including calcium ions and hydration, as part of the molecular arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.